Design Therapeutics, Inc. (DSGN) income statement
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.02−0.30 (-3.22%)
Close on Nov 20, 2026Market cap $564.49MP/E –Yield –
Design Therapeutics, Inc. financial ratios
See a number that looks wrong?